Cargando…

SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice

The COVID-19 pandemic has been fueled by SARS-CoV-2 novel variants of concern (VOC) that have increased transmissibility, receptor binding affinity, and other properties that enhance disease. The goal of this study is to characterize unique pathogenesis of the Delta VOC strain in the K18-hACE2-mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Katherine S., Wong, Ting Y., Russ, Brynnan P., Horspool, Alexander M., Miller, Olivia A., Rader, Nathaniel A., Givi, Jerome P., Winters, Michael T., Wong, Zeriel Y. A., Cyphert, Holly A., Denvir, James, Stoilov, Peter, Barbier, Mariette, Roan, Nadia R., Amin, Md. Shahrier, Martinez, Ivan, Bevere, Justin R., Damron, F. Heath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423646/ https://www.ncbi.nlm.nih.gov/pubmed/36037222 http://dx.doi.org/10.1371/journal.pone.0273430

Ejemplares similares

Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2
por: Lee, Katherine S., et al.
Publicado: (2022)

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
por: Wong, Ting Y., et al.
Publicado: (2022)

Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2
por: Barbier, Mariette, et al.
Publicado: (2022)

Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
por: Lee, Katherine S, et al.
Publicado: (2023)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
por: Wong, Ting Y., et al.
Publicado: (2022)

Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
por: Wong, Ting Y., et al.
Publicado: (2022)

SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
por: Horspool, Alexander M., et al.
Publicado: (2021)

Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection
por: Horspool, Alexander M., et al.
Publicado: (2021)

Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats
por: Hall, Jesse M., et al.
Publicado: (2021)

Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
por: Diallo, Béré K., et al.
Publicado: (2023)

Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia
por: Sen-Kilic, Emel, et al.
Publicado: (2021)

Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
por: Rodriguez-Aponte, Sergio A., et al.
Publicado: (2023)

Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis
por: Hall, Jesse M., et al.
Publicado: (2021)

Rainbow Vectors for Broad-Range Bacterial Fluorescence Labeling
por: Barbier, Mariette, et al.
Publicado: (2016)

Innate and Adaptive Immune Responses against Bordetella pertussis and Pseudomonas aeruginosa in a Murine Model of Mucosal Vaccination against Respiratory Infection
por: Blackwood, Catherine B., et al.
Publicado: (2020)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
por: Sen-Kilic, Emel, et al.
Publicado: (2019)

Protocol for aerosolization challenge of mice with Bordetella pertussis
por: Bitzer, Graham, et al.
Publicado: (2023)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice
por: Zheng, Jian, et al.
Publicado: (2020)

Analysis of the In Vivo Transcriptome of Bordetella pertussis during Infection of Mice
por: Wong, Ting Y., et al.
Publicado: (2019)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia
por: Damron, F. Heath, et al.
Publicado: (2016)

P. aeruginosa type III and type VI secretion systems modulate early response gene expression in type II pneumocytes in vitro
por: Sen-Kilic, Emel, et al.
Publicado: (2022)

The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)

Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2
por: Glazkova, D. V., et al.
Publicado: (2022)

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice
por: Su, Ping, et al.
Publicado: (2022)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2020)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
por: DeDiego, Marta L., et al.
Publicado: (2008)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Rodriguez, Jorge H.
Publicado: (2021)

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
por: Moreau, Gregory Brett, et al.
Publicado: (2020)

Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
por: Golden, Joseph W., et al.
Publicado: (2021)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
por: Kumari, Pratima, et al.
Publicado: (2021)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
por: Bian, Lianlian, et al.
Publicado: (2022)

Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice
por: Weaver, Kelly L., et al.
Publicado: (2022)

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
por: Linsky, Thomas W., et al.
Publicado: (2020)

Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice
por: Kang, Jason, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g6tnltnf5c9qdlh9j8r9473mf0